Paolo Marchetti

Pubblicazioni

Titolo Pubblicato in Anno
Commentary on "a case of paratesticular leiomyosarcoma successfully treated with orchiectomy and chemotherapy" CANCER RESEARCH AND TREATMENT 2016
Pre-treatment evaluation of 5-fluorouracil degradation rate. association of poor and ultra-rapid metabolism with severe toxicity in a colorectal cancer patients cohort ONCOTARGET 2016
CYP19A1 Genetic Polymorphisms rs4646 and Osteoporosis in Patients Treated with Aromatase Inhibitor-Based Adjuvant Therapy THE EURASIAN JOURNAL OF MEDICINE 2016
Evolving treatments for advanced gastric cancer: appraisal of the survival trend EXPERT REVIEW OF ANTICANCER THERAPY 2016
Targeting immune response with therapeutic vaccines in premalignant lesions and cervical cancer: hope or reality from clinical studies EXPERT REVIEW OF VACCINES 2016
H2020 and beyond: skip discrepancy between theory and practice of personalized medicine. A position paper by the italian society of personalized medicine CURRENT PHARMACEUTICAL BIOTECHNOLOGY 2016
The TYMS-TSER polymorphism is associated with toxicity of low-dose capecitabine in patients with advanced gastrointestinal cancer ANTI-CANCER DRUGS 2016
High prevalence of ALK+/ROS1+ cases in pulmonary adenocarcinoma of adoloscents and young adults LUNG CANCER 2016
Pre-treatment assay of 5-fluorouracil degradation rate (5-FUDR) to improve prediction of 5-fluorouracil toxicity in gastro-esophageal cancer ONCOTARGET 2016
Degradation rate of 5-fluorouracil in metastatic colorectal cancer. A new predictive outcome biomarker? PLOS ONE 2016
5-Fluorouracil degradation rate could predict toxicity in stages II-III colorectal cancer patients undergoing adjuvant FOLFOX ANTI-CANCER DRUGS 2016
Neoadjuvant sequential docetaxel followed by high-dose epirubicin in combination with cyclophosphamide administered concurrently with trastuzumab. The DECT trial JOURNAL OF CELLULAR PHYSIOLOGY 2016
Metabolic determinants and anthropometric indicators impact clinical-pathological features in epithelial ovarian cancer patients JOURNAL OF CANCER 2016
Exploring the Prognostic Role of Microsatellite Instability in Patients With Stage II Colorectal Cancer: A Systematic Review and Meta-Analysis CLINICAL COLORECTAL CANCER 2016
Safety analysis, association with response and previous treatments of everolimus and exemestane in 181 metastatic breast cancer patients. A multicenter Italian experience THE BREAST 2016
A rare case of palatin tonsillar metastasis from small cell lung cancer TRANSLATIONAL LUNG CANCER RESEARCH 2016
High-doses of proton pump inhibitors in refractory gastro-intestinal cancer: A case series and the state of art DIGESTIVE AND LIVER DISEASE 2016
Re. "Awareness and consideration of malnutrition among oncologists: Insights from an exploratory survey" NUTRITION 2016
Ethics in oncology: Principles and responsibilities declared in the Italian Ragusa statement TUMORI 2016
Bevacizumab as first-line treatment in HER2-negative advanced breast cancer. Pros and cons TUMORI 2016

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma